Literature DB >> 9817449

Brain mast cells lack the c-kit receptor: immunocytochemical evidence.

U Shanas1, R Bhasin, A K Sutherland, A J Silverman, R Silver.   

Abstract

Mast cells are reported to differ from other cells of the hematopoietic lineage in that as mature cells, they retain the c-kit receptor, and are thus capable of responding to the stem cell factor (SCF) ligand. SCF is important for development and survival of mast cells. In this study, c-kit expression was examined immunocytochemically in the brains of mice, rats and doves. The results indicate that brain mast cells lack the c-kit receptor; those of the leptomeninges and other connective tissues are a mixed population of c-kit positive and negative cells. The mechanisms whereby brain mast cells might survive in the absence of SCF-c-kit signaling are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817449     DOI: 10.1016/s0165-5728(98)00137-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Brain mast cell relationship to neurovasculature during development.

Authors:  Mona Khalil; Jocelyn Ronda; Michael Weintraub; Kim Jain; Rae Silver; Ann-Judith Silverman
Journal:  Brain Res       Date:  2007-07-26       Impact factor: 3.252

Review 3.  Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage.

Authors:  Perttu Johannes Lindsberg; Daniel Strbian; Marja-Liisa Karjalainen-Lindsberg
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

Review 4.  Investigating the aetiology of adverse events following HPV vaccination with systems vaccinology.

Authors:  Joan Campbell-Tofte; Aristidis Vrahatis; Knud Josefsen; Jesper Mehlsen; Kaj Winther
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

Review 5.  Mast cell and autoimmune diseases.

Authors:  Yunzhi Xu; Guangjie Chen
Journal:  Mediators Inflamm       Date:  2015-04-05       Impact factor: 4.711

6.  Involvement of premacular mast cells in the pathogenesis of macular diseases.

Authors:  Takaki Sato; Seita Morishita; Taeko Horie; Masanori Fukumoto; Teruyo Kida; Hidehiro Oku; Kimitoshi Nakamura; Shinji Takai; Denan Jin; Tsunehiko Ikeda
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

7.  Enduring neuroimmunological consequences of developmental experiences: From vulnerability to resilience.

Authors:  Jack Reddaway; Nichola M Brydges
Journal:  Mol Cell Neurosci       Date:  2020-10-14       Impact factor: 4.314

Review 8.  Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases.

Authors:  Jagdeep K Sandhu; Marianna Kulka
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

Review 9.  Prion disease and the innate immune system.

Authors:  Barry M Bradford; Neil A Mabbott
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.